Tuttle Craig James 4
4 · TRANSGENOMIC INC · Filed May 7, 2013
Insider Transaction Report
Form 4
TRANSGENOMIC INCTBIO.OB
Tuttle Craig James
DirectorPresident and CEO
Transactions
- Award
Purchase Option
2013-05-03+83,333→ 83,333 totalExercise: $0.35From: 2015-06-01Exp: 2023-05-02→ Common Stock (83,333 underlying) - Award
Purchase Option
2013-05-03+83,333→ 83,333 totalExercise: $0.35From: 2016-06-01Exp: 2023-05-02→ Common Stock (83,333 underlying) - Award
Purchase Option
2013-05-03+83,334→ 83,334 totalExercise: $0.35From: 2014-06-01Exp: 2023-05-02→ Common Stock (83,334 underlying)
Footnotes (2)
- [F1]Common Stock, par value $.01 per share of Transgenomic, Inc.
- [F2]The various numbers listed in Columns 5, 7 and 9 relate to a single option grant which entitles the reporting person to purchase up to an aggregate of 250,000 shares of Common Stock, par value $.01 per share of Transgenomic, Inc.